HKSH Cancer Centre Promotes Widespread Adoption of Precision Medicine Collaboration with FWD Hong Kong and Roche Diagnostics to Enhance Awareness of Comprehensive Genomic Profiling

(2 July 2025, Hong Kong) HKSH Cancer Centre (HKSH) has always been committed to providing patients with one-stop, comprehensive services for cancer screening, diagnosis, treatment, and rehabilitation, ensuring that every patient receives the highest level of support throughout their cancer-fighting journey. Recently, HKSH has partnered with FWD Hong Kong (FWD) and Roche Diagnostics (Hong Kong) Limited (Roche) to raise public awareness on precision medicine and cancer genomic testing. HKSH’s oncology specialists will share the latest development in cancer diagnosis and treatment through FWD MAX lifestyle experience platform (fwdmax.fwd.com.hk), introducing Comprehensive Genomic Profiling (CGP) and other cutting-edge medical technologies. This collaboration aims to help more patients to benefit from precise and personalised treatments, ultimately improving patient outcome and their quality of life.

Please click here for more information.